[96a5a0]: / output / allTrials / identified / NCT02960620_identified.json

Download this file

349 lines (349 with data), 15.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
{
"info": {
"nct_id": "NCT02960620",
"official_title": "A Humanitarian Device Exemption (HDE) Treatment Protocol of TheraSphere® For Treatment of Unresectable Primary or Secondary Liver Neoplasia - HDE #980006",
"inclusion_criteria": "* Patients will be recruited from the patient population referred to the principal clinician for regional liver cancer therapy.\n* Potential candidates are those diagnosed with primary or secondary liver neoplasia. The histopathology confirmation criterion may be waived in patients with a radiographically identifiable liver mass, known laboratory or clinical risk factors for cancer or elevated tumor markers and clinical findings. Guidelines from the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL) describe in detail the approach and algorithm for diagnosing Hepatocellular Carcinoma (HCC).\n* Eastern Cooperative Oncology Group (ECOG) Performance Status Score 0 - 2\n* Life expectancy ≥ 3 months\n* > 4 weeks since prior radiation, surgery or chemotherapy\n* Able to comprehend and provide consent in accordance with institutional and federal guidelines\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Any other liver therapy planned for cancer treatment\n* Uncorrectable flow to the gastrointestinal tract\n* Estimated radiation doses to the lungs greater than 30 Gy in a single administration or 50 Gy in multiple administrations\n* Significant extrahepatic disease representing imminent life-threatening outcome\n* Pregnancy",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients will be recruited from the patient population referred to the principal clinician for regional liver cancer therapy.",
"criterions": [
{
"exact_snippets": "regional liver cancer",
"criterion": "liver cancer",
"requirements": [
{
"requirement_type": "region",
"expected_value": "regional"
}
]
}
]
},
{
"line": "* Potential candidates are those diagnosed with primary or secondary liver neoplasia. The histopathology confirmation criterion may be waived in patients with a radiographically identifiable liver mass, known laboratory or clinical risk factors for cancer or elevated tumor markers and clinical findings. Guidelines from the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL) describe in detail the approach and algorithm for diagnosing Hepatocellular Carcinoma (HCC).",
"criterions": [
{
"exact_snippets": "diagnosed with primary or secondary liver neoplasia",
"criterion": "liver neoplasia",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": [
"primary",
"secondary"
]
}
]
},
{
"exact_snippets": "histopathology confirmation criterion may be waived",
"criterion": "histopathology confirmation",
"requirements": [
{
"requirement_type": "waived",
"expected_value": true
}
]
},
{
"exact_snippets": "radiographically identifiable liver mass",
"criterion": "liver mass",
"requirements": [
{
"requirement_type": "identifiability",
"expected_value": "radiographically"
}
]
},
{
"exact_snippets": "known laboratory or clinical risk factors for cancer",
"criterion": "risk factors for cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "known laboratory or clinical"
}
]
},
{
"exact_snippets": "elevated tumor markers",
"criterion": "tumor markers",
"requirements": [
{
"requirement_type": "level",
"expected_value": "elevated"
}
]
},
{
"exact_snippets": "clinical findings",
"criterion": "clinical findings",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Eastern Cooperative Oncology Group (ECOG) Performance Status Score 0 - 2",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) Performance Status Score 0 - 2",
"criterion": "ECOG Performance Status Score",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Life expectancy ≥ 3 months",
"criterions": [
{
"exact_snippets": "Life expectancy ≥ 3 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "* > 4 weeks since prior radiation, surgery or chemotherapy",
"criterions": [
{
"exact_snippets": " > 4 weeks since prior radiation",
"criterion": "time since prior radiation",
"requirements": [
{
"requirement_type": "time since",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": " > 4 weeks since prior ... surgery",
"criterion": "time since prior surgery",
"requirements": [
{
"requirement_type": "time since",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": " > 4 weeks since prior ... chemotherapy",
"criterion": "time since prior chemotherapy",
"requirements": [
{
"requirement_type": "time since",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Able to comprehend and provide consent in accordance with institutional and federal guidelines",
"criterions": [
{
"exact_snippets": "Able to comprehend",
"criterion": "comprehension ability",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "provide consent",
"criterion": "consent capability",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Any other liver therapy planned for cancer treatment",
"criterions": [
{
"exact_snippets": "Any other liver therapy planned for cancer treatment",
"criterion": "liver therapy",
"requirements": [
{
"requirement_type": "planned",
"expected_value": false
}
]
}
]
},
{
"line": "* Uncorrectable flow to the gastrointestinal tract",
"criterions": [
{
"exact_snippets": "Uncorrectable flow to the gastrointestinal tract",
"criterion": "flow to the gastrointestinal tract",
"requirements": [
{
"requirement_type": "correctability",
"expected_value": false
}
]
}
]
},
{
"line": "* Estimated radiation doses to the lungs greater than 30 Gy in a single administration or 50 Gy in multiple administrations",
"criterions": [
{
"exact_snippets": "Estimated radiation doses to the lungs greater than 30 Gy in a single administration",
"criterion": "radiation dose to the lungs",
"requirements": [
{
"requirement_type": "dose",
"expected_value": {
"operator": ">",
"value": 30,
"unit": "Gy"
}
},
{
"requirement_type": "administration type",
"expected_value": "single"
}
]
},
{
"exact_snippets": "Estimated radiation doses to the lungs ... 50 Gy in multiple administrations",
"criterion": "radiation dose to the lungs",
"requirements": [
{
"requirement_type": "dose",
"expected_value": {
"operator": ">",
"value": 50,
"unit": "Gy"
}
},
{
"requirement_type": "administration type",
"expected_value": "multiple"
}
]
}
]
},
{
"line": "* Significant extrahepatic disease representing imminent life-threatening outcome",
"criterions": [
{
"exact_snippets": "Significant extrahepatic disease",
"criterion": "extrahepatic disease",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
},
{
"exact_snippets": "imminent life-threatening outcome",
"criterion": "life-threatening outcome",
"requirements": [
{
"requirement_type": "imminence",
"expected_value": true
}
]
}
]
},
{
"line": "* Pregnancy",
"criterions": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}